Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Healthequity (HQY) Non-Current Deffered Revenue (2016 - 2019)

Healthequity (HQY) has 6 years of Non-Current Deffered Revenue data on record, last reported at $3.0 million in Q1 2019.

  • For Q1 2019, Non-Current Deffered Revenue rose 23.92% year-over-year to $3.0 million; the TTM value through Jan 2019 reached $3.0 million, up 23.92%, while the annual FY2019 figure was $3.0 million, 23.92% up from the prior year.
  • Non-Current Deffered Revenue reached $3.0 million in Q1 2019 per HQY's latest filing, up from $2.5 million in the prior quarter.
  • Across five years, Non-Current Deffered Revenue topped out at $3.0 million in Q1 2019 and bottomed at $145000.0 in Q3 2015.
  • Average Non-Current Deffered Revenue over 5 years is $1.3 million, with a median of $1.3 million recorded in 2016.
  • Peak YoY movement for Non-Current Deffered Revenue: plummeted 66.67% in 2015, then surged 642.07% in 2016.
  • A 5-year view of Non-Current Deffered Revenue shows it stood at $195000.0 in 2015, then soared by 564.1% to $1.3 million in 2016, then skyrocketed by 71.89% to $2.2 million in 2017, then grew by 10.78% to $2.5 million in 2018, then increased by 20.36% to $3.0 million in 2019.
  • Per Business Quant database, its latest 3 readings for Non-Current Deffered Revenue were $3.0 million in Q1 2019, $2.5 million in Q2 2018, and $2.4 million in Q1 2018.